Johnson & Johnson to Participate in the UBS Global Healthcare Conference
21 April 2022 - 6:30AM
PR Newswire (US)
NEW
BRUNSWICK, N.J., April 20,
2022 /PRNewswire/ -- Johnson & Johnson (NYSE:
JNJ) will participate in the UBS Global Healthcare Conference on
Tuesday, May 24th.
Mathai Mammen, Executive Vice
President, Pharmaceuticals R&D, will represent the Company in a
session scheduled at 10:00 a.m. (Eastern
Time).
This webcast will be available to investors and other interested
parties by accessing the Johnson & Johnson website at
www.investor.jnj.com.
A webcast replay will be available approximately 48 hours after
the live webcast.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-ubs-global-healthcare-conference-301529498.html
SOURCE Johnson & Johnson
Copyright 2022 PR Newswire
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024